ADIPOQ and polycystic ovary syndrome: Adiponectin, an anti-inflammatory and insulin-sensitizing adipokine, was significantly lower in obese PCOS women (5.2 ± 1.4 μg/mL vs. 7.8 ± 1.9 μg/mL, p=0.002).